Transplant Diagnostics Market Overview and Introduction

Since the first successful organ transplantation in 1953, number of organ transplants have witnessed exponential growth ever since. This has directly resulted in the better understanding of basic immunological processes associated with organ transplantation, rejection and allograft tolerance. Transplantation is a routine and well-established strategy used for end­stage lung, liver, kidney and heart diseases. New predictive and diagnostic monitoring tools are increasingly being used to deliver customized immunosuppressive drugs for optimal organ & patient care.

Several factors have triggered the adoption of advanced transplant diagnostics processes to maintain cater to the growing demand for organ transplants worldwide. Rising incidences & prevalence of cardiac diseases, kidney dysfunction, orthopedic injuries and lungs disorders among the global population, has been crucial in triggering the need for effective transplant diagnostic processes to obtain fruitful organ transplant outcomes. Similarly, advent of novel technologies have been significant in complimenting the global transplant diagnostics market. On the contrary, existence of considerable gap between demand & supply of organs and restrictions on reimbursement policies for target procedures are anticipated to restrain the transplant diagnostics market to a certain extent.

The global transplant diagnostics market is majorly classified into the following segments, viz., by product & services, technology, application, transplant type, end user and region.

Transplant Diagnostics Market by Product & Services

The segment of product & services can be further categorized into, reagents & consumables, software & services and instruments. The reagents & consumables is anticipated to account for the largest share in the global transplant diagnostics market in 2019. The large share of this segment can be attributed to recurring use associated with these products, and rising number of organ transplants globally.

Transplant Diagnostics Market by Technology

On the basis of technology, transplant diagnostics market is bifurcated into two major segments, i.e., molecular assay technologies and non-molecular assay technologies. The molecular assay technologies can be classified into PCR-Based molecular assay technologies, and sequencing-based molecular assay technologies. PCR-Based molecular assay technologies can further be segmented into real-time PCR, Sequence-Specific Oligonucleotide-PCR (SSO-PCR), Sequence-Specific Primer-PCR (SSP-PCR) and other PCR technologies. Whereas, segment of sequencing-based molecular assay technologies can be divided into Sanger sequencing, next-generation sequencing, and other sequencing technologies.

Transplant Diagnostics Market by Application

On the basis of application, transplant diagnostics market is bifurcated into the following segments, i.e., diagnostic applications and research applications. The diagnostic applications can further be classified into Pre-Transplantation and Post-Transplantation. The diagnostic applications segment accounted for the largest share in the market in 2019, owing to factors such as rising incidences of chronic disorders and growing geriatric population.

Transplant Diagnostics Market by Transplant Type

On the basis of transplant type, the transplant diagnostics market is bifurcated into stem cell transplantation, soft tissue transplantation, and solid organ transplantation. The segment of solid organ transplantation can further be classified into heart, lung, liver, kidney, pancreas and others. Solid organ transplantation segment accounted for the largest share in the global transplant diagnostics marker, owing to rising demand for organs globally.

Transplant Diagnostics Market by End User

On the basis of end user, transplant diagnostics market has be classified into research laboratories and academic institutions, hospitals and transplant centers and others.

Transplant Diagnostics Market by Region

The global transplant diagnostics market can be segmented into North America, Asia Pacific, Europe and Rest of World (ROW). North America dominated the global transplant diagnostics market in 2019, owing to factors such as availability of favorable health insurance policies or schemes, high funding & investments for R&D of novel technologies in transplant diagnostics, and rising geriatric population among others.

Transplant Diagnostics Market Prominent Players

The prominent players operating in the global transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Illumina, Inc., Merck KGaA, Immucor Transplant Diagnostics, GenDx, Luminex Corporation and Omixon Inc. among others